Tipepidine in Children With Attention Deficit/Hyperactivity Disorder (AD/HD): a Double-blind, Placebo-controlled Trial
PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment
21
Participants
Timeline
Start Date
June 11, 2015
Primary Completion Date
March 31, 2019
Study Completion Date
March 31, 2019
Conditions
Attention Deficit Disorder With Hyperactivity DiseaseHyperkinesisAttention Deficit and Disruptive Behavior Disorders
Interventions
DRUG
Tipepidine Hibenzate
DRUG
Placebo
Trial Locations (1)
260-8670
Department of Psychiatry, Chiba University School of Medicine, Chiba
All Listed Sponsors
lead
Chiba University
OTHER
NCT02305134 - Tipepidine in Children With Attention Deficit/Hyperactivity Disorder (AD/HD): a Double-blind, Placebo-controlled Trial | Biotech Hunter | Biotech Hunter